Illumina reagents and services

The Department of Health's, Bureau of Public Health Laboratories has the need to purchase the Illumina MiSeq®, iSeq ®, and NextSeq ® system reagents and services for the identification of nucleic acid sequences. These instruments and reagents will support the outbreak detection activities for enteric and viral diseases and are required by the Centers for Disease Control and Prevention (CDC).  In accordance with Chapter 60A-1.045, Florida Administrative Code, the Florida Department of Health, BPHL, requests authorization to purchase, as a single source, the MiSeq®, iSeq ®, and NextSeq ® System reagents and services from Illumina, Inc.